Today @JAMAOnc published results of the MAGENTA study by @SwisherLab, @LizSwisher & @KarenLuMD. In 3.8k participants, skipping counseling after screening for inherited risk for cancer did not increase distress for those with negative results. Learn more at https://t.co/VlzOUxadB3
Drug Discovery, Development, and Novel Pathways:
Timothy A. Yap, Sarah F. Adams, @KatherineFuh, and Jung-min Lee will address this topic in a plenary at the AACR Special Conference on Ovarian Cancer (Oct 5-7, Boston). Learn more:
https://t.co/dMrwTjdKPb
#AACRovc23@SwisherLab
@AnneMillsMD@Aetna So frustrating. I spend hours doing these appeals for my cancer patients, usually to no avail. My patients have literally said to me "my insurance company wants me to die" and I have no answer.
@Andrew_Akbashev 💯 ! also, there's the nepotism inherent in unblinded review and the publication IFs of women and minority scientists are lower not because of poor science. Hanging too much on IFs in hiring and promotion contributes to discrimination and reduces diversity. Impact matters not IFs
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing https://t.co/N08LpdrM0b organoid directed drug testing performed by @SEngineMedicine directed tx literally rescued a #LGSOC pt from the brink of death!👇🚨 #lowgradeserous
It really does not matter if a fertilized egg is a person or not. As long as I can’t force you to donate a kidney or bone marrow or part of your liver to save a life, you can’t force anyone to risk their life and health with a pregnancy. https://t.co/BecqB7q0H5
First ovarian cancer survivor in history @Jess.Wedel just summited Mt Everest! Truly amazing! We join the team to focus on #ovariancancer prevention
@drjmhope@SwisherLiz@StephanieVBlank @DKhabeleMD
Donate: https://t.co/fzhvVDKn0T…
Website:
https://t.co/KlueiZckll